Skip to main content
Mobile menu expand icon
Menu
Close
About Gimv
Investment platforms
Anchor investments
Portfolio
Team
News
Investors
en
Search
*
(Optional)
Submit
About Gimv
Investment platforms
Anchor investments
Portfolio
Team
News
Investors
Sustainability
Working at/with Gimv
Contact
Search results Search results Search results
Search results
Search
*
(Optional)
Apply
1 - 550 of 952 results
Topas Therapeutics raises EUR 22 Million in Series B Financing and appoints new CEO
Press release
See more info
Gimv and founder sell Eurocept Homecare - active in ’Hospital-at-home‘ services and complex wound care - to Mediq
Press release
See more info
The Köberl Group starts a growth initiative with the acquisition of 089 Immobilienmanagement GmbH
Press release
See more info
Strong results on the back of a resilient portfolio
Press release
See more info
Gimv invests in SynOx Therapeutics which raises EUR 37 million to develop emactuzumab for treatment of tenosynovial giant cell tumors
Press release
See more info
Kind Technologies acquires Martin Stolze for further growth within the horticulture greenhouse market
Press release
See more info
Gimv is founding investor of Kinaset Therapeutics in a USD 40m Series A round – funds used to develop novel therapeutics for respiratory diseases
Press release
See more info
ImCheck Presents at SITC First Clinical Demonstration of Gamma Delta T Cell Activation and Tumor Infiltration with Positive Safety for ICT01
Press release
See more info
Gimv sells Itho Daalderop-Climate for Life - Dutch market leader in integrated sustainable solutions for energy-neutral living in the Benelux - to Parcom
Press release
See more info
Cegeka reinforces international position by acquiring KPN Consulting
Press release
See more info
Pagination
See more results